Singapore, Nov. 5 -- Seoul National University Bundang Hospital (SNUBH) in Seoul, South Korea has been awarded a three-year term of accreditation by the Global Healthcare Accreditation (GHA) Program f... Read More
Singapore, Nov. 5 -- In a move to better serve people living with and without diabetes, Boehringer Ingelheim and Eli Lilly and Company will modernise their current alliance as of 1 January 2020 and fo... Read More
Singapore, Nov. 5 -- Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a portfolio of select products to STADA Arzneimittel AG, an international pharm... Read More
Singapore, Nov. 5 -- Cerecin, a global healthcare company focused on developing brain health solutions and therapeutics for patients around the world, on 4 Nov 2019, announced the appointment of Bruce... Read More
Singapore, Nov. 5 -- Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, in collaboration with the Seoul Metropolitan Government and Korea Health Industry Development Institute (KHIDI), have anno... Read More
Singapore, Nov. 5 -- Shimmer Research, a global leader in wearable technology for research applications, on 4 Nov 2019, announced that ECGmd - its five-wire, four-lead holter monitor electrocardiograp... Read More
Singapore, Nov. 5 -- The U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application for Fluzone(R) High-Dose Quadrivalent (Influenza Vaccine) for use in adults 6... Read More
Singapore, Nov. 5 -- Samsung Biologics has announced the signing of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal antibody in develop... Read More
Singapore, Nov. 5 -- Simcere Pharmaceutical Group and Aeromics, Inc. have announced collaboration and exclusive license agreement for AER-271, a clinical-stage anti-edema therapy, being developed for ... Read More
Singapore, Nov. 5 -- SciRhom GmbH, a therapeutic antibody company, announced on 5 Nov 2019 its development of first-in-class antibodies against iRhom2, a key modulator of several major pro-inflammator... Read More